Anne Osdoit Overview
- Company
- MD Start
- Primary Position
-
Co-Founder & Par...
- Primary Industry
-
Healthcare
- Active Board Seats
-
3
- Med. Deal Size
-
Anne Osdoit General Information
Biography
Ms. Anne Osdoit is a Co-Founder & serves as Partner - MD Start II & MD Start III at MD Start. Ms. Osdoit serves as a Partner in strategy at Sofinnova Partners. She Co-founded and served as President and Board Member at SafeHeal. She serves as Chief Executive Officer at Moon Surgical. She also serves as a Board Observer at HighLife. She served as a Board Director at Cardiologs. She serves as a Partner, at MDStart Fund at Sofinnova Partners. She also serves as President and Chief Executive Officer at Gradient Denervation Technologies. She serves as Board Member at AblaCare. She served as Board Member at FeetMe. At Mauna Kea Technologies, she held various positions in clinical and regulatory development as well as marketing and sales support. She was also heavily involved in the different financing rounds as well as in the IPO process. She interfaced with the key opinion leaders and has an extensive network in the fields of endoscopy and surgery (digestive, pulmonary, and urological mostly, but not exclusively). Having lived and worked in hospital environments in the USA and the UK, she can translate unmet medical needs into product projects and integrate input from all around the world. She is an Advisory Board member of Cardiologs (France). She serves as a Board Observer at FeetMe. She is a trained biomedical engineer from Ecole Polytechnique of Paris, France and Johns Hopkins University in Baltimore, US. She holds additional degrees in Biostatistics and epidemiology applied to clinical trials (Université Pierre et Marie Curie), as well as Corporate Finance (London School of Economics).
Contact Information
Address
- Sofinnova MD Start III
- 7-11 Boulevard Haussmann
- 75009 Paris
- France
Anne Osdoit Positions (3)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
MD Start | Company | Co-Founder & Partner - MD Start II & MD Start III | Paris, France | Consulting Services (B2B) | |
Moon Surgical | Company | Chief Executive Officer, Chairman & President | Paris, France | Surgical Devices | |
Sofinnova Partners | Investor | Partner, MDStart Strategy | Paris, France | Venture Capital |
Anne Osdoit Board Seats (3)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
HighLife | Therapeutic Devices | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
May Health | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
Sofinnova Partners | Private Equity | Privately Held (backing) | Private Equity-Backed | Paris, France |
Anne Osdoit Lead Partner on Deals (5)
Anne Osdoit has been the lead partner on 5 deals. Their latest deal was with Pi-Cardia, a surgical devices company. The deal was made for on 20-Apr-2020.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Pi-Cardia | 20-Apr-2020 | Later Stage VC (Series C) | Completed | Surgical Devices | Rehovot, Israel | |
Gradient Denervation Technologies | 01-Feb-2020 | Completed | Other Devices and Supplies | Suresnes, France | ||
May Health | 01-Jan-2017 | Completed | Surgical Devices | Paris, France | ||
SafeHeal | 01-Jan-2015 | Accelerator/Incubator | Completed | Therapeutic Devices | Paris, France | |
SafeHeal | Seed Round | Completed | Therapeutic Devices | Paris, France |
Anne Osdoit Network (78)
Board Members (32)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Antoine Papiernik | SafeHeal | Sofinnova Partners | Paris, France | |
Antoine Papiernik | HighLife | Sofinnova Partners | Paris, France | |
May Health | Sofinnova Partners | Paris, France | ||
Sofinnova Partners | Sofinnova Partners | Paris, France | ||
SafeHeal | Self | Paris, France |
Portfolio Executives (28)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Ronnie Levy | Pi-Cardia | Chief Operating Officer | 20-Apr-2020 | Rehovot, Israel |
Erez Golan | Pi-Cardia | Founder & Chief Executive Officer | 20-Apr-2020 | Rehovot, Israel |
Pi-Cardia | Co-Founder & Chief Executive Officer | 20-Apr-2020 | Rehovot, Israel | |
Pi-Cardia | Co-Founder | 20-Apr-2020 | Rehovot, Israel | |
Pi-Cardia | Co-Founder & Executive Director | 20-Apr-2020 | Rehovot, Israel |
Fund Team Members (18)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Maina Bhaman | Sofinnova Partners | Sofinnova Capital IX | Paris, France |
Maina Bhaman | Sofinnova Partners | Sofinnova Telethon Fund I | Paris, France |
Sofinnova Partners | Paris, France | ||
Sofinnova Partners | Paris, France | ||
MD Start | Paris, France |
Anne Osdoit Affiliated Funds (5)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Sofinnova MD Start III Fund | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2020 | ||||
Sofinnova Capital IX | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2020 | ||||
Sofinnova Telethon Fund I | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2018 | ||||
MD Start I | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2008 | ||||
MD Start II | Sofinnova Partners | Venture Capital - Early Stage | Closed | 2015 |
Anne Osdoit FAQs
-
Who is Anne Osdoit?
Ms. Anne Osdoit is a Co-Founder & serves as Partner - MD Start II & MD Start III at MD Start.
-
How much does Anne Osdoit typically invest?
Anne Osdoit's median deal size is
. -
What is Anne Osdoit’s main position?
Anne Osdoit’s primary position is Co-Founder & Partner - MD Start II & MD Start III.
-
How many active board seats does Anne Osdoit hold?
Anne Osdoit holds 3 board seats including HighLife, May Health, and Sofinnova Partners.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »